Showing results 1 to 20 of 94
next >
| Issue Date | Title | Author(s) |
| 2012 | THE ANATOMICAL RETROPERITONEOSCOPIC NEPHRECTOMY -THE NEW CONCEPT AND ITS SAFETY | Zhou, Liqun; Song, Gang; He, Zhisong; Song, Yi; Wang, Gang; Wu, Shiliang |
| 2017 | The Application of Internal Suspension Technique in Retroperitoneal Laparoscopic Partial Nephrectomy for Renal Ventral Tumors | Zhong, Wenlong; Du, Yicong; Zhang, Lei; Li, Xuesong; Zhang, Cuijian; Fang, Dong; Xiong, Gengyan; He, Zhisong; Zhou, Liqun |
| 2017 | Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age? | Ji, Guangjie; Huang, Cong; Song, Gang; Xiong, Gengyan; Fang, Dong; Wang, He; Hao, Han; Cai, Lin; He, Qun; He, Zhisong; Zhou, Liqun |
| Jun-2023 | Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer | Lei, Huizi; Ling, Yun; Yuan, Pei; Yan, Xieqiao; Wang, Lin; Shi, Yanxia; Yao, Xin; Luo, Hong; Shi, Benkang; Liu, Jiyan; He, Zhisong; Yu, Guohua; Han, Weiqing; Hu, Changlu; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Fang, Jianmin; Guo, Jun; Sheng, Xinan; Zhou, Aiping; Ying, Jianming |
| 2015 | Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients | Fang, Dong; Liu, Pei; Li, Xuesong; Xiong, Gengyan; Zhang, Lei; Singla, Nirmish; Zhao, Guangzhi; He, Qun; He, Zhisong; Zhou, Liqun |
| 1-Jun-2022 | Clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma. | He, Zhisong; Hu, Hailong; Niu, Yuanjie; Guo, Zhaoxia; Ding, Feng; Wang, Yunkai; Wang, Wang; Zhou, Tao; Cao, Shanbo; Lou, Feng; Wang, Huina |
| Oct-2023 | Clinical-Kidney Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy | Huang, Jiwei; Su, Ruopeng; Zhang, Cuijian; Bao, Yige; Hu, Xiaoyi; Ye, Xiongjun; Chen, Minfeng; Wang, Ping; Wu, Jitao; Wang, Yueming; Tang, Qi; Huang, Zhiyang; Zheng, Bing; Li, Chancan; Guo, Jianming; Huang, Yiran; Wei, Qiang; He, Zhisong; Xue, Wei |
| 2017 | Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature | Zhong, Wenlong; Lin, Rongcheng; Zhang, Lei; Jin, Chengyue; Li, Xuesong; He, Qun; Gong, Kan; He, Zhisong; Zhou, Liqun |
| 2016 | Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer | Yao, Lin; Yang, Kunlin; Li, Xuesong; Zhang, Zheng; Zhang, Cuijian; Gong, Kan; Xi, Zhijun; He, Zhisong; Zhou, Liqun |
| Dec-2023 | Comparison of Targeted Biopsy and Combined Biopsy to Avoid Unnecessary Systematic Biopsy in Patients with PI-RADS 5 Lesions | Yuan, Changwei; Li, Derun; Wu, Jingyun; Shen, Qi; Wang, Xiaoying; Xiao, Jiangxi; He, Zhisong; Zhou, Liqun; Li, Xuesong; Liu, Yi; Zhao, Zheng |
| 2015 | Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation | Zhang, Lei; Xiong, Gengyan; Fang, Dong; Li, Xuesong; Liu, Jin; Ci, Weimin; Zhao, Wei; Singla, Nirmish; He, Zhisong; Zhou, Liqun |
| 2012 | The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases | Zhang, Cuijian; Li, Xuesong; Hao, Han; Yu, Wei; He, Zhisong; Zhou, Liqun |
| 2012 | Cystic Schwannoma of a Seminal Vesicle | He, Rui; Yang, Xinyu; Li, Xuesong; He, Zhisong; Zhou, Liqun |
| Dec-2020 | Development and internal validation of nomograms for the prediction of postoperative survival of patients with grade 4 renal cell carcinoma (RCC) | Zhu, Jun; Liu, Zhifu; Zhang, Zhongyuan; Fan, Yu; Chen, Yuke; He, Zhisong; Zhou, Liqun; Jin, Jie; Shen, Cheng; Yu, Wei |
| 2018 | Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation | Peng, Ding; Ge, Guangzhe; Xu, Zhengzheng; Ma, Qin; Shi, Yue; Zhou, Yuanyuan; Gong, Yanqing; Xiong, Gengyan; Zhang, Cuijian; He, Shiming; He, Zhisong; Li, Xuesong; Ci, Weimin; Zhou, Liqun |
| 1-Jun-2023 | Disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate (ADC), combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma: An open-label phase 1b/2 study. | Sheng, Xinan; Zhou, Li; Yang, Kaiwei; Zhang, Shun; Xu, Huayan; Yan, Xieqiao; Li, Siming; Li, Juan; Cui, Chuanliang; Chi, Zhihong; Si, Lu; Tang, Bixia; Mao, Lili; Lian, Bin; Wang, Xuan; Bai, Xue; He, Zhisong; Guo, Hongqian; Guo, Jun |
| 1-Feb-2024 | Efficacy and safety between first-line therapies in metastatic castration-resistant prostate cancer in combination in the PARPi and ARSI era: A systematic review and network meta-analysis. | Guo, Xuanjun; Li, Yixin; Wang, Mengying; Peng, Hexiang; Guo, Huangda; Hou, Tianjiao; Zhang, Hanyu; Jiang, Jin; Sheng, Tao; Fan, Yu; Wu, Tao; He, Zhisong |
| 20-Apr-2024 | Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials | Sheng, Xinan; Wang, Lin; He, Zhisong; Shi, Yanxia; Luo, Hong; Han, Weiqing; Yao, Xin; Shi, Benkang; Liu, Jiyan; Hu, Changlu; Liu, Ziling; Guo, Hongqian; Yu, Guohua; Ji, Zhigang; Ying, Jianming; Ling, Yun; Yu, Shiying; Hu, Yi; Guo, Jianming; Fang, Jianmin; Zhou, Aiping; Guo, Jun |
| 2010 | ELL is an HIF-1 alpha Partner That Regulates and Responds to Hypoxia Response in PC3 Cells | Liu, Lingqi; Ai, Junkui; Xiao, Wuhan; Liu, June; Wang, Yujuan; Xin, Dianqi; He, Zhisong; Guo, Yinglu; Wang, Zhou |
| 2019 | Endoscopic balloon dilation vs ureteral reimplantation for the treatment of primary obstructive megaureter: a meta-analysis of case series studies | Yang, Kunlin; Wang, Gang; Zhong, Wenlong; Li, Xuesong; Yao, Lin; Zhang, Zheng; He, Zhisong; Zhou, Liqun |
